KarXT, Trimethobenzamide, Ondansetron, Meclizine — catalyst calendar

1 verified catalyst event(s) referencing KarXT, Trimethobenzamide, Ondansetron, Meclizine, each linked to its official source. Verified as of 2026-09-20.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-11-30
in 2mo
ESTIMATED
READOUT
Study to Assess Safety and Tolerability of KarXT With Administration of Antiemet
Phase 4 · Healthy Volunteers
Karuna Therapeutics, Inc., a Brist KarXT, Trimethobenzamide, Ondansetron, M ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.